Neurosensory Disorder Clinical Trial
Official title:
A Randomized, Controlled, Single-center Clinical Study of Huperzine A in the Treatment of Brain Injury in Patients With Hypertensive Cerebral Hemorrhage
1. To evaluate the effectiveness of Huperzine A injection in the treatment of brain injury
in patients with hypertensive cerebral hemorrhageï¼›
2. To evaluate the safety of Huperzine A injection in the treatment of brain injury in
patients with hypertensive cerebral hemorrhage。
A randomized, controlled, single-center, exploratory clinical research method was used. In the treatment plan, the experimental group used basic treatment + Huperzine A, and the control group only used basic treatment, with a total of 20 cases. To evaluate the effectiveness and safety of Huperzine A injection in the treatment of brain injury in patients with hypertensive cerebral hemorrhage. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05536596 -
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03159338 -
Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy
|
N/A | |
| Recruiting |
NCT03952663 -
Effect of Platelet Rich Fibrin Membrane on the Neurosensory Dysfunction After IAN Lateralization for Implant Placement.
|
N/A | |
| Completed |
NCT05811741 -
Impact of Mandibular Canal Trajectory on Paresthesia After Inferior Alveolar Nerve Lateralization
|
||
| Recruiting |
NCT04706182 -
Platelet-rich Fibrin and Grooving for Sagittal Split Osteotomy
|
N/A |